Chimeric extracellular domain of type II transforming growth factor (TGF)-β receptor fused to the Fc region of human immunoglobulin as a TGF-β antagonist

European Journal of Biochemistry

Volumn 254, Issue 3, 1998, Pages 505-513

  Komesli, Sylviane ^a   Vivien, Denis ^b   Dutartre, Patrick ^a  

^a Laboratoires Fournier SA   (France)

^b CNRS   (France)

Author keywords

Chimeric receptor; Human transforming growth factor ; Transforming growth factor antagonist; Transforming growth factor receptor

Indexed keywords

FC RECEPTOR; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CHIMERA; CONFORMATIONAL TRANSITION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; RECEPTOR DENSITY;

ANIMALS; BASE SEQUENCE; COS CELLS; DNA PRIMERS; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IODINE RADIOISOTOPES; PROTEIN BINDING; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RECOMBINANT FUSION PROTEINS; SOLUBILITY; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 0032525922     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1998.2540505.x     Document Type: Article

References (52)

1. Massagué, J. (1990) The transforming growth factor-β family. Annu. Rev. Cell Biol. 6, 597-641.
2. Massugué, J., Attisano, L. & Wrana, J. L. (1994) Advance in TGF-β, Trends Cell Biol. 4, 172-178.
3. Border, W. A. & Noble, N. A. (1994) Transforming growth factor β in tissue fibrosis, N. Engl. J. Med. 331, 1286-1292.
4. Jennings, J. C., Mohan, S., Linkhart, T. A., Widstrom, R. & Baylink, D. J. (1988) Comparison of the biological actions of TGF beta-1 and TGF beta-2: differential activity in endothelial cells. J. Cell. Physiol. 137, 167-172.
5. 2 in vitro, Am. J. Pathol. 138, 37-51.
6. Ottmann, O. G. & Pelus, L. M. (1988) Differential proliferate effects of transforming growth factor-β on human hematopoietic progenitor cells, J. Immunol. 140, 2661-2665.
7. Ohta, M., Greenberger, J. S., Anklesaria, P., Bassols, A. & Massagué, J. (1987) Two forms of transforming growth factor-β distinguished by multipotential haematopoetic progenitor cells, Nature 329, 539-541.
8. Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., Annunziata, N. & Doetschman, T. (1992) Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease, Nature 359, 693-699.
9. Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M. & Karlsson, S. (1993) Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl Acad. Sci. USA 90, 770-774.
10. Dickson, M. C., Martin, J. S., Cousins, F. M., Kulkarni, A. B., Karlsson, S. & Akhurst, R. J. (1995) Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice, Development 121, 1845-1854.
11. Martin, J. S., Dickson, M. C., Cousins, F. M., Kulkarni, A. B., Karlsson, S. & Akhurst, R. J. (1995) Analysis of homozygous TGF beta 1 null mouse embryos demonstrates defects in yolk sac vasculogenesis and hematopoiesis. Ann. NY Acad. Sci. 752, 300-308.
12. Yaswen, L., Kulkarni, A. B., Fredrickson, T., Mittleman, B., Schiffmann, R., Payne, S., Longenecker, G., Mozes, E. & Karlsson, S. (1996) Autoimmune manifestations in the transforming growth faclor-β1 knockout mouse, Blood 87, 1439-1445.
13. Nath, R. K., LaRegina, M., Markham, H., Ksander, G. A. & Weeks, P. M. (1994) The expression of transforming growth factor type beta in fetal and adult rabbit skin wounds, J. Ped. Surg. 29, 416-421.
14. Mustoe, T. A., Pierce, G. F., Thomason, A., Gramates, P., Sporn, M. B. & Deuel, T. F. (1987) Accelerated healing of incisional wounds in rats induced by transforming growth factor-β, Science 237, 1333-1336.
15. Border, W. A. & Ruoslahti, E. (1992) Transforming growth factor β disease: the dark side of tissue repair, J. Clin. Invest. 90, 1-7.
16. Border, W. A. & Noble, N. A. (1993) Cytokines in kidney disease: the role of transforming growth factor β, Am. J. Kidney Dis. 22, 105-113.
17. Yamamoto, T., Noble, N. A., Cohen, A. H., Nast, C. C., Hishida, A., Gold, L. I. & Border, W. A. (1995) Expression of transforming growth factor β isoforms in human glomerular disease, Kidney Int. 49, 461-469.
18. Shihab, F. S., Yamamoto, T., Nast, C. C., Cohen, A. H., Noble, N. A., Gold, L. I. & Border, W. A. (1995) Transforming growth factor-β and matrix protein expression in acute and chronic rejection of human renal allogralts, J. Am. Soc. Nephrol. 6, 286-294.
19. Demirci, G., Nashan, B. & Pichlmayr, R. (1996) Fibrosis in chronic rejection of human liver allografts, Transplantation 12, 1776-1783.
20. Gauldie, J., Jordana, M. & Cox, G. (1993) Cytokines and pulmonary fibrosis, Thorax 48, 931-935.
21. Broekelmann, T. J., Limper, A. H., Colby, T. V. & McDonald J. A. (1991) Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis, Proc. Natl Acad Sci. USA 88, 6642-6646.
22. Sanvito, F., Nichols, A., Herrera, P. L., Huarte, J., Wohlwend, A., Vassalli, J. D. & Orci, L. (1995) TGF-β1 overexpression in murine pancreas induces chronic pancreatitis and, together with TNF-α, triggers insulin-dependent diabetes, Biochem. Biophys. Res. Commun. 217, 1279-1286.
23. Kopp, J. B., Factor, V. M., Mozes, M., Nagy, P., Sanderson, N., Bottinger, E. P., Klotman, P. E. & Thorgeirsson, S. S. (1996) Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease, Lab. Invest. 74, 991-1003.
24. Sime, P. J., Xing, Z., Graham, F. L., Csaky, K. G. & Gauldie, J. (1997) Adenovector-mediated gene transfer of active transforming growth factor-β1 induces prolonged severe fibrosis in rat lung, J Clin. Invest. 100, 768-776.
25. Massagué, J. (1992) Receptors for TGF β family, Cell 69, 1067-1070.
26. Lin, H. Y., Wang, X. F., Ng-Eaton, E., Weinberg, R. A. & Lodish, H. F. (1992) Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase, Cell 68, 775-785.
27. Franzen, P., ten Dijke, P., Ichija, H., Yamashita, H., Schulz, P., Heldin, C. H. & Miyazona, K. (1993) Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor, Cell 75, 681-692.
28. Bassing, C. H., Yingling, J. M., Howe, D. J., Wang, T., He, W. W., Gustafson, M. L., Shah, P., Donahal, P. K. & Wang, X. F. (1994) A transforming growth factor β type I receptor that signals to activate gene expression, Science 263, 87-89.
29. Wang, X. F., Lin, H. Y., Ng-Eaton, E., Downward, J., Lodish, H. F. & Weinberg, R. A. (1991) Expression cloning and characterization of the TGF-β type III receptor, Cell 67, 797-805.
30. Lopez-Casillas, F., Cheifetz, S., Doody, J., Andres, J. L., Lane, W. S. & Massagué, J. (1991) Structure and expression of the membrane proteoglycan, a component of the TGF-β receptor system, Cell 67, 785-795.
31. Wrana, J. L., Attisano, L., Carcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X. F. & Massagué, J. (1992) TGFβ signals through a heteromeric protein kinase receptor complex, Cell 71, 1003-1014.
32. Henis, Y. I., Moustakas, A., Lin, H. Y. & Lodish, H. F. (1994) The types II and III transforming growth factor-β receptors form homo-oligomers, J. Cell Biol. 126, 139-154.
33. Laiho, M., Weis, F. M. B. & Massagué, J. (1990) Concomitant loss of transforming growth factor (TGF)-β receptor types I and II in TGF-β-resistant cell mutants implicates both receptor types in signal transduction, J. Biol. Chem. 265, 18519-18524.
34. Laiho, M., Weis, F. M. B., Boyd, F. T., Ignotz, R. A. & Massagué, J. (1991) Responsiveness to transforming growth factor-β (TGF-β) restored by genetic complementation between cells defective in TGF-β receptors I and II, J. Biol. Chem. 266, 9108-9112.
35. Vivien, D., Attisano, L., Wrana, J. L. & Massagué, J. (1995) Signaling activity of homologous and heterologous transforming growth factor-β receptor kinase complexes, J. Biol. Chem. 270, 7134-7141.
36. Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L. C., Bapat, B., Gallinger, S., Andrulis, I. L., Thomsen, G. H., Wrana, J. L. & Attisano, L. (1996) MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is funtionally mutated in colorectal carcinoma, Cell 86, 543-552.
37. Hayashi, H., Abdollah, Y. Q., Cai, J., Xu, Y.-Y., Grinnell, B. W., Richardson, M. A., Topper, J. N., Grimbrone, M. A., Wrana, J. L. & Falb, D. (1997) The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling, Cell 89, 1165-1173.
38. Lin, H. Y., Moustakas, A., Knaus, P., Wells, R. G., Henis, Y. I. & Lodish, H. F. (1995) The soluble exoplasmic domain of the type II transforming growth factor (TGF)-beta receptor. A heterogeneously glycosylated protein with high affinity and selectivity for TGF-beta ligands. J. Biol. Chem. 10, 2747-2754.
39. Goetschy, J. F., Letourneur, O., Cerletti, N. & Horisberger, M. A. (1996) The unglycosylated extracellular domain of type-II receptor for transforming growth factor-β, Eur. J. Biochem. 241, 355-362.
40. Tsang, M. L. S., Zhou, L., Zheng, B. L., Wenker, J., Fransen, G., Humphrey, J., Smith, J. M., O'Connor-McCourt, M., Lucas, R. & Weatherbee, J. A. (1995) Characterization of recombinant soluble human transforming growth factor-beta receptor type II (rhTGF-beta sRII), Cytokine 5, 389-397.
41. Lopez-Casillas, F., Payne, H. M., Andres, J. L. & Massagué, J. (1994) Betaglycan can act as a dual modulator of TGF-β access to signaling receptors: mapping of ligand binding and GAG attachment sites, J. Cell Biol. 124, 557-568.
42. Border, W. A., Noble, N. A., Yamamoto, T., Harper, J. R., Yamaguchi, Y., Pierschbacher, M. D. & Ruoslahti, E. (1992) Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease, Nature 360, 361-364.
43. Isaka, Y., Brees, D. K., Ikegaya, K., Kaneda, Y., Imai, E., Noble, N. A. & Border, W. A. (1996) Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney, Nature Med. 2, 418-423.
44. Sanger, F., Nicklen, S. & Coulson, A. R. (1977) DNA sequencing with chain-terminating inhibitors, Proc. Natl Acad. Sci. USA 74, 5463-5467.
45. Wigler, M., Sweet, R., Sim, G. K., Wold, B., Pellicer, A., Lacy, E., Maniatis, T., Silverstein, S. & Axel, R. (1979) Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell 16, 777-785.
46. Cheifetz, S., Weatherbee, J. A., Tsang, M. L., Anderson, J. K., Mole, J. E., Lucas, R. & Massagué, J. (1987) The transforming growth factor-β system, a complex pattern of cross-reactive ligands receptors, Cell 48, 409-415.
47. Attisano, L., Carcamo, J., Ventura, F., Weis, M. B., Massagué, J. & Wrana, J. L. (1993) Identification of human activin and TGF β type I receptors that form heteromeric kinase complexes with type II receptors, Cell 75, 671-680.
48. Vivien, D. & Wrana, J. L. (1995) Ligand-induced recruitment and phosphorylation of reduced TGF-beta type I receptor, Exp. Cell Res. 221, 60-65.
49. O'Connor-McCourt, M. D., Segarini, P., Grothe, S., Tsang, L.-S. & Weatherbee, J. A. (1995) Analysis of the interaction between two TGF-β-binding proteins and three TGF-β isoforms using surface plasmon resonance, Ann. NY Acad. Sci. 766, 300-302.
50. Letourneur, O., Goetschy, J. F., Horisberger, M. & Grutter, M. G. (1996) Ligand-induced dimerization of the extracellular domain of the TGF-β receptor type II, Biochem. Biophys. Res. Commun. 224, 709-716.
51. Cheifetz, S., Hernandez, H., Laiho, M., ten Dijke, P., Iwata, K. K. & Massagué, J. (1990) Distinct transforming growth factor-beta (TGF-beta) receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms. J. Biol. Chem. 265, 20533-20838.
52. Tsang, M. L. S., Weatherbee, J. A., Dietz, M., Kitamura, T. & Lucas, R. C. (1990) TGF-beta specifically inhibits the 1L-4 dependant proliferation of multifactor-dependent murine T-helper and human hematopoietic cell lines, Lymphokine Res. 9, 607.